We are live on
!
Find out more
PCM
Prelude Capital Management Portfolio holdings
AUM
$1.31B
1-Year Est. Return
62.02%
This Fund
S&P 500
This Quarter
Est. Return
+19.61%
1 Year Est. Return
+62.02%
3 Year Est. Return
+164.16%
5 Year Est. Return
+274.13%
10 Year Est. Return
+2,470.2%
AUM
$2.63B
AUM Growth
+$411M
(+19%)
Cap. Flow
+$161M
Cap. Flow
% of AUM
6.13%
Top 10 Holdings %
Top 10 Hldgs %
44.92%
Holding
2,471
New
804
Increased
452
Reduced
440
Closed
595
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Netflix
NFLX
|
+$13.4M |
| 2 |
BOLD
Audentes Therapeutics, Inc
BOLD
|
+$10.5M |
| 3 |
CISN
Cision Ltd. Ordinary Share
CISN
|
+$10M |
| 4 |
MDCO
Medicines Co
MDCO
|
+$8.78M |
| 5 |
TIF
Tiffany & Co.
TIF
|
+$7.91M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
CELG
Celgene Corp
CELG
|
+$42.5M |
| 2 |
VSM
Versum Materials, Inc.
VSM
|
+$29.7M |
| 3 |
ONCE
Spark Therapeutics, Inc. Common Stock
ONCE
|
+$23.3M |
| 4 |
AABA
Altaba Inc
AABA
|
+$18.8M |
| 5 |
CPE
Callon Petroleum Company
CPE
|
+$17.2M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 4.59% |
| 2 | Healthcare | 3.78% |
| 3 | Consumer Discretionary | 3.06% |
| 4 | Communication Services | 2.48% |
| 5 | Real Estate | 2.08% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
GES
1501
DELISTED
Guess Inc
GES
| $28K | ﹤0.01% |
+1,259
| New | +$23.5K |
|
1502
La-Z-Boy
LZB
$1.69B
| $28K | ﹤0.01% |
+895
| New | +$30K |
|
1503
CALL
The Mosaic Company
MOS
$7.33B
| $28K | ﹤0.01% |
1,300
-200
| -13% | -$3.97K |
|
1504
CALL
Pitney Bowes
PBI
$2.39B
| $28K | ﹤0.01% |
7,000
-1,000
| -13% | -$4.58K |
|
1505
Paylocity
PCTY
$7.98B
| $28K | ﹤0.01% |
230
-40
| -15% | -$4.38K |
|
|
DBD
1506
DELISTED
Diebold Nixdorf Incorporated
DBD
| $28K | ﹤0.01% |
+2,639
| New | +$23.4K |
|
|
VWTR
1507
CALL
DELISTED
Vidler Water Resouces, Inc. Common Stock
VWTR
| $28K | ﹤0.01% |
2,500
-200
| -7% | -$2.13K |
|
1508
Apyx Medical
APYX
$171M
| $27K | ﹤0.01% |
+3,134
| New | +$22.6K |
|
1509
Archrock
AROC
$5.8B
| $27K | ﹤0.01% |
+2,699
| New | +$25.2K |
|
1510
AptarGroup
ATR
$8.61B
| $27K | ﹤0.01% |
235
-15
| -6% | -$1.71K |
|
1511
CPI Aerostructures
CVU
$68.5M
| $27K | ﹤0.01% |
4,000
+1,492
| +59% | +$11K |
|
1512
Fabrinet
FN
$20.1B
| $27K | ﹤0.01% |
+422
| New | +$24.4K |
|
1513
Healthcare Services Group
HCSG
$1.53B
| $27K | ﹤0.01% |
+1,109
| New | +$27.5K |
|
1514
Nature's Sunshine
NATR
$288M
| $27K | ﹤0.01% |
3,044
+633
| +26% | +$5.94K |
|
|
GHL
1515
DELISTED
Greenhill & Co., Inc.
GHL
| $27K | ﹤0.01% |
+1,606
| New | +$26.1K |
|
|
NPTN
1516
DELISTED
NEOPHOTONICS CORP
NPTN
| $27K | ﹤0.01% |
3,100
-14,300
| -82% | -$107K |
|
|
VSLR
1517
DELISTED
VIVINT SOLAR, INC.
VSLR
| $27K | ﹤0.01% |
+3,751
| New | +$26.5K |
|
|
WPG
1518
DELISTED
Washington Prime Group Inc.
WPG
| $27K | ﹤0.01% |
+811
| New | +$29.4K |
|
1519
Howard Hughes
HHH
$4.03B
| $26K | ﹤0.01% |
216
-256
| -54% | -$28.4K |
|
1520
NETGEAR
NTGR
$635M
| $26K | ﹤0.01% |
1,058
-346
| -25% | -$9.46K |
|
1521
OptimizeRx
OPRX
$133M
| $26K | ﹤0.01% |
2,501
-135
| -5% | -$1.53K |
|
|
GRTS
1522
DELISTED
Gritstone bio, Inc. Common Stock
GRTS
| $26K | ﹤0.01% |
+2,862
| New | +$23.9K |
|
1523
CDW
CDW
$17B
| $25K | ﹤0.01% |
+175
| New | +$23.2K |
|
1524
HNI Corp
HNI
$3.59B
| $25K | ﹤0.01% |
+669
| New | +$25.6K |
|
1525
Monopar Therapeutics
MNPR
$799M
| $25K | ﹤0.01% |
+302
| New | +$31.5K |
|
Similar funds
PFBT
CCP
SP
HCS
SPC
GPCM
MCM
CC
Prelude Capital Management's Q4 2019 Portfolio in Review
As of Q4 2019, Prelude Capital Management held 2,471 positions worth $2.63B, up 19% from $2.22B the previous quarter. Its ten largest holdings account for 45% of the portfolio.
Prelude Capital Management deployed $161M of net new capital in Q4 2019, opening 804 new positions and adding to 452 existing holdings. Its largest new stake was Netflix: 452,870 shares worth $14.7M.
By sector, the portfolio is most concentrated in Technology at 4.6% of assets, down from 6.3% a quarter earlier, followed by Healthcare and Consumer Discretionary.
On the sell side, the largest reduction was Callon Petroleum Company, an estimated $17.2M trimmed.
- Prelude Capital Management's largest Q4 2019 buy was Netflix: 452,870 shares worth $14.7M.
- Prelude Capital Management added most to Cision Ltd. Ordinary Share in Q4 2019, an estimated $10M increase.
- Prelude Capital Management's biggest Q4 2019 reduction was Callon Petroleum Company, cutting an estimated $17.2M.
- Prelude Capital Management fully exited Celgene Corp in Q4 2019, selling an estimated $42.5M.
- Prelude Capital Management's ten largest holdings make up 45% of its $2.63B portfolio in Q4 2019.
- Prelude Capital Management opened 804 new positions and closed 595 in Q4 2019.
- Prelude Capital Management's portfolio value rose 19% quarter-over-quarter to $2.63B.
Based on Prelude Capital Management's 13F filing for Q4 2019, filed 14 Feb 2020.